 "Dr Reddy's")
Dr Reddy’s Laboratories Ltd will pay $5 million to resolve US claims that the Indian company sold prescription drugs in the United States in packaging that was not tested for child safety, according to court papers filed on Monday.
The settlement was disclosed in documents filed in federal court in Trenton, New Jersey, over a year after the US Consumer Product Safety Commission voted to refer a case involving the drugmaker to the US Justice Department.
Dr Reddy’s in a statement said that the safety of patients and consumers was of “paramount importance” to the company. It said it disagreed with the
